CPRX Stock Analysis — The Undervalued Biotech Wall Street Ignored

Описание: While everyone’s chasing AI hype, one small biotech quietly beat Big Pharma — and locked down its future until 2035.
Catalyst Pharmaceuticals (CPRX) isn’t a moonshot. It’s a money machine.
With strong profits, zero debt, and a fortress balance sheet, this could be the smartest defensive play in biotech right now.
Let’s break down the fundamentals, the chart setup, and the story Wall Street’s been sleeping on.

Disclaimer: Education and entertainment only, not financial advice.

#cprx
#usstock
#investing
#robinhood
#tdameritrade